FDA’s New Plan to Study Opioids’ Effectiveness Faces Resistance

April 19, 2023

(STAT News) – The Food and Drug Administration’s latest plan to study whether opioids are effective as a chronic pain treatment is facing significant resistance from addiction and pain care experts. A planned clinical trial, doctors and researchers argued on Wednesday, would not yield significant new information about whether opioids are effective as long-term treatments for chronic pain. The study, some charged, would be biased in favor of opioids’ efficacy — and by extension, biased in favor of painkiller manufacturers. (Read More)